Role of the kinin B1 receptor in insulin homeostasis and pancreatic islet function

Biological Chemistry

Volumn 387, Issue 4, 2006, Pages 431-436

  Araújo, Ronaldo C ^a   Mori, Marcelo A ^b   Merino, Vanessa F ^b   Bascands, Jean Loup ^c   Schanstra, Joost P ^c   Zollner, Ricardo L ^d   Villela, Conceição A ^d   Nakaie, Clovis R ^b   Paiva, Antonio C M ^b   Pesquero, Jorge L ^a   Bader, Michael ^e   Pesquero, João B ^b  

^a UNIVERSIDADE DE MOGI DAS CRUZES   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c CHU RANGUEIL   (France)

^d UNIVERSITY OF CAMPINAS   (Brazil)

^e MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

Diabetes; Glucose; Insulin; Kinin B1 receptor; Kinins; Pancreas

Indexed keywords

BRADYKININ; GLUCOSE; INSULIN; KININ; KININ BETA 1 RECEPTOR; KININ RECEPTOR; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG; BRADYKININ B1 RECEPTOR; BRADYKININ, DES ARG(9); BRADYKININ, DES-ARG(9)-; DRUG DERIVATIVE; VASODILATOR AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETOGENESIS; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; INSULIN HOMEOSTASIS; INSULIN RELEASE; INSULIN SENSITIVITY; INSULIN SYNTHESIS; MOUSE; NONHUMAN; PANCREAS BLOOD FLOW; PANCREAS ISLET BETA CELL; PHENOTYPE; PRIORITY JOURNAL; SPECIES COMPARISON; WILD TYPE; ANIMAL; BLOOD; C57BL MOUSE; CAPILLARY PERMEABILITY; DRUG POTENTIATION; HYPERGLYCEMIA; METABOLISM; PANCREAS ISLET; PHYSIOLOGY; TIME;

ANIMALIA;

ANIMALS; BLOOD GLUCOSE; BRADYKININ; CAPILLARY PERMEABILITY; HOMEOSTASIS; HYPERGLYCEMIA; INSULIN; ISLETS OF LANGERHANS; MICE; MICE, INBRED C57BL; RECEPTOR, BRADYKININ B1; TIME FACTORS; VASODILATOR AGENTS;

EID: 33645760265     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/BC.2006.057     Document Type: Article

References (35)

1. Araújo, R.C., Kettritz, R., Fichtner, I., Paiva, A.C.M., Pesquero, J.B., and Bader, M. (2001). Altered neutrophil homeostasis in kinin B1 receptor-deficient mice. Biol. Chem. 382, 91-95.
2. Bhoola, K.D., Figueroa, C.D., and Worthy, K. (1992). Bioregulation of kinins: kallikreins, kininogens, and kininases. Pharmacol. Rev. 44, 1-80.
3. Chai, K.X., Ni, A., Wang, D., Ward, D.C., Chao, J., and Chao, L. (1996). Genomic DNA sequence, expression, and chromosomal localization of the human B1 bradykinin receptor gene BDKRB1. Genomics 31, 51-57.
4. Chen, D., Mauvais-Jarvis, F., Bluher, M., Fisher, S.J., Jozsi, A., Goodyear, L.J., Ueki, K., and Kahn, C.R. (2004). p50α/p55α phosphoinositide 3-kinase knockout mice exhibit enhanced insulin sensitivity. Mol. Cell. Biol. 24, 320-329.
5. Christopher, J. and Jaffa, A.A. (2002). Diabetes modulates the expression of glomerular kinin receptors. Int. Immunopharmacol. 2, 1771-1779.
6. 1-kinin receptors in vascular smooth muscle cells: cellular mechanisms of MAP kinase activation. Hypertension 38, 602-605.
7. 2-kinin receptors by glucose in vascular smooth muscle cells. Am. J. Physiol. Heart Circ. Physiol. 280, H1537-1546.
8. 2 receptor agonists in the spinal cord of streptozotocin-diabetic rats. Br. J. Pharmacol. 130, 375-385.
9. Damas, J., Bourdon, V., and Lefebvre, P.J. (1999). Insulin sensitivity, clearance and release in kininogen-deficient rats. Exp. Physiol. 84, 549-557.
10. 2 receptor of bradykinin in insulin sensitivity. Hypertension 38, 1355-1360.
11. Emanueli, C., Grady, E.F., Madeddu, P., Figini, M., Bunnett, N.W., Parisi, D., Regoli, D., and Geppetti, P. (1998). Acute ACE inhibition causes plasma extravasation in mice that is mediated by bradykinin and substance P. Hypertension 31, 1299-1304.
12. Gabra, B.H. and Sirois, P. (2003). Beneficial effect of chronic treatment with the selective bradykinin B1 receptor antagonists, R-715 and R-954, in attenuating streptozotocin-diabetic thermal hyperalgesia in mice. Peptides 8, 1131-1139.
13. Gotoh, M., Maki, T., Kiyoizumim, T., Satomi, S., and Monaco, A.P. (1985). An improved method for isolation of mouse pancreatic islets. Transplantation 40, 437-438.
14. Henriksen, E.J. and Jacob, S. (2003). Modulation of metabolic control by angiotensin converting enzyme (ACE) inhibition. J. Cell. Physiol. 196, 171-179.
15. Henriksen, E.J., Jacob, S., Kinnick, T.R., Youngblood, E.B., Schmit, M.B., and Dietze, G.J. (1999). ACE inhibition and glucose transport in insulin resistant muscle: roles of bradykinin and nitric oxide. Am. J. Physiol. 277, R332-R336.
16. Isami, S., Kishikawa, H., Araki, E., Uehara, M., Kaneko, K., Shirotani, T., Todaka, M., Ura, S., Motoyoshi, S., Matsumoto, K., et al. (1996). Bradykinin enhances GLUT4 translocation through the increase of insulin receptor tyrosine kinase in primary adipocytes: evidence that bradykinin stimulates the insulin signalling pathway. Diabetologia 39, 412-420.
17. Kishi, K., Muromoto, N., Nakaya, Y., Miyata, I., Hagi, A., Hayashi, H., and Ebina, Y. (1998). Bradykinin directly triggers GLUT4 translocation via an insulin-independent pathway. Diabetes 47, 550-558.
18. Konstantinova, I. and Lammert, E. (2004). Microvascular development: learning from pancreatic islets. Bioessays 26, 1069-1075.
19. Kuebler, J.F., Schremmer-Danninger, E., Bhoola, K.D., Roscher, A.A., Messmer, K., and Hoffmann, T.F. (2003). Kinin-B1 receptors in ischaemia-induced pancreatitis: functional importance and cellular localisation. Biol. Chem. 384, 1311-1319.
20. Lawson, S.R., Gabra, B.H., Guerin, B., Neugebauer, W., Nantel, F., Battistini, B., and Sirois, P. (2005). Enhanced dermal and retinal vascular permeability in streptozotocin-induced type 1 diabetes in Wistar rats: blockade with a selective bradykinin B1 receptor antagonist. Regul. Pept. 124, 221-224.
21. Leeb-Lundberg, L.M., Marceau, F., Muller-Esterl, W., Pettibone, D.J., and Zuraw, B.L. (2005). International union of pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences. Pharmacol. Rev. 57, 27-77.
22. Levesque, L., Lam, M.H., Allaire, P., Mondat, M., Houle, S., Beaudoin, G., Donath, D., and Leclerc, G. (2001). Effects of radiation therapy on vascular responsiveness. J. Cardiovasc. Pharmacol. 37, 381-393.
23. Lukinius, A., Jansson, L., and Korsgren, O. (1995). Ultrastructural evidence for blood microvessels devoid of an endothelial cell lining in transplanted pancreatic islets. Am. J. Pathol. 146, 429-435.
24. Marceau, F. and Regoli, D. (2004). Bradykinin receptor ligands: therapeutic perspectives. Nat. Rev. Drug Discov. 3, 845-852.
25. Minami, A., Iseki, M., Kishi, K., Wang, M., Ogura, M., Furukawa, N., Hayashi, S., Yamada, M., Obata, T., Takeshita, Y., et al. (2003). Increased insulin sensitivity and hypoinsulinemia in APS knockout mice. Diabetes 52, 2657-2665.
26. Pelikanova, T., Pinsker, P., Smrckova, I., Stribrna, L., and Dryakova, M. (1998). Decreased urinary kallikrein with hyperglycemia in patients with short-term insulin-dependent diabetes mellitus. J. Diabetes Complications 12, 264-272.
27. Pesquero, J.B., Pesquero, J.L., Oliveira, S.M., Roscher, A., Metzger, R., Ganten, D., and Bader, M. (1996). Molecular cloning and functional characterization of a mouse bradykinin B1 receptor gene. Biochem. Biophys. Res. Commun. 220, 219-225.
28. 1 receptors. Proc. Natl. Acad. Sci. USA 97, 8140-8145.
29. Rodríguez, A., Pereira K, Boric MP, Velarde V. (2005). High glucose or hyperglycemia increases B1-kinin receptor expression and signaling in endothelial cells. In: XVIth Scientific Meeting of the Inter American Society of Hypertension, Cancun, Mexico.
30. Simard, B., Gabra, B.H., and Sirois, P. (2002). Inhibitory effect of a novel bradykinin B1 receptor antagonist, R-954, on enhanced vascular permeability in type 1 diabetic mice. Can. J. Physiol. Pharmacol. 80, 1203-1207.
31. Tschope, C., Walther, T., Yu, M., Reinecke, A., Koch, M., Seligmann, C., Heringer, S.B., Pesquero, J.B., Bader, M., Schultheiss, H., and Unger, T. (1999a). Myocardial expression of rat bradykinin receptors and two tissue kallikrein genes in experimental diabetes. Immunopharmacology 15, 35-42.
32. Tschope, C., Reinecke, A., Seidl, U., Yu, M., Gavriluk, V., Riester, U., Gohlke, P., Graf, K., Bader, M., Hilgenfeldt, U., et al. (1999b). Functional, biochemical, and molecular investigations of renal kallikrein-kinin system in diabetic rats. Am. J. Physiol. 277, H2333-2340.
33. Yang, C. and Hsu, W.H. (1995). Stimulatory effect of bradykinin on insulin release from the perfused rat pancreas. Am. J. Physiol. 268, E1027-E1030.
34. Yang, C. and Hsu, W.H. (1997). Glucose-dependency of bradykinin-induced insulin secretion from the perfused rat pancreas. Regul. Pept. 71, 23-28.
35. Zuccollo, A., Navarro, M., Frontera, M., Cueva, F., Carattino, M., and Catanzaro, O.L. (1999). The involvement of kallikreinkinin system in diabetes type I (insulitis). Immunopharmacology 45, 69-74.